Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

George Newman

Diagnostic Radiology Birmingham, AL Medical Doctor

NPI 1891088670 CMS profile 1295267

341 Kingston Cir, Birmingham, AL 35211

Open in the dashboard

General payments

$15,281

148 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, George Newman of Birmingham, AL is reported in the CMS Open Payments database as having received $15,281 across 148 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,805 55
2024 General $5,348 40
2023 General $1,378 17
2022 General $789 12
2021 General $920 12
2020 General $494 7
2019 General $547 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Newman
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to George Newman were reported at $5,805. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year George Newman Diagnostic Radiology median Middle half National median
2019 $547 $108 $29–$318 $163
2020 $494 $65 $21–$252 $114
2021 $920 $92 $24–$292 $132
2022 $789 $104 $29–$294 $149
2023 $1,378 $110 $29–$337 $160
2024 $5,348 $113 $30–$356 $164
2025 $5,805 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $9,084 56 payments
  2. Inari Medical, Inc. $2,551 32 payments
  3. Stryker Corporation $1,027 12 payments
  4. Boston Scientific Corporation $663 13 payments
  5. Sirtex Medical Inc $504 7 payments
  6. Ethicon US, LLC $367 6 payments
  7. Canon Medical Systems USA, Inc. $317 2 payments
  8. Bard Peripheral Vascular, Inc. $236 5 payments
  9. Biocompatibles, Inc. $141 1 payment
  10. Intuitive Surgical, Inc. $120 1 payment
  11. Other $272 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,989 140 payments
  2. Travel and Lodging $4,292 8 payments
Products named General payments · program years 2019–2025
  1. Indigo System $6,353 31 payments
  2. CT THROMBECTOMY SYSTEM KIT $2,746 33 payments
  3. FLOWTRIEVER CATHETER, S $2,746 33 payments
  4. Penumbra System $1,477 13 payments
  5. RUBY Coil $703 5 payments
  6. FLOWTRIEVER $577 6 payments
  7. SIR-Spheres Microspheres $483 6 payments
  8. Certus 140 $284 5 payments
  9. Ruby $272 4 payments
  10. GENERAL DEVICE(S) $241 1 payment
  11. Other $2,081 42 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Diagnostic Radiology: 24

Drug cost

$44

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 13 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 196 billing codes

Paid by Medicare

$91,683

Medicare's payments for the services billed

Medicare patients

1,463

Average age 75

Services billed

2,320

827 women, 636 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Ischemic heart disease 39%
Diabetes 36%
Chronic kidney disease 36%
Heart failure 29%
COPD 29%
Cancer 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

148 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record